Study participants were randomly assigned 2:1 to receive oral semaglutide 25mg (n=205) or placebo (n=102), as an adjunct to lifestyle intervention. The coprimary endpoints were the relative change in ...

The review extension was needed as the FDA required time to review Cytokinetics’ proposed Risk Evaluation and Mitigation Strategy (REMS).

The replicate confirmatory KALOS and LOGOS trials evaluated BGF in participants with severe asthma inadequately controlled with standard of care.

Nipocalimab-aahu is a human immunoglobulin G1 monoclonal antibody that binds with high affinity to the neonatal Fc receptor, resulting in the reduction of circulating IgG levels.

The Food and Drug Administration (FDA) has granted Fast Track designation to bempikibart for the treatment of alopecia areata (AA).

Elamipretide, a cell-permeable peptide compound, is designed to improve mitochondrial function by targeting the inner mitochondrial membrane where it binds reversibly to cardiolipin.

Outbreak mainly affected members of communities with low measles vaccination coverage in New Mexico, Oklahoma, and Texas.

The Food and Drug Administration (FDA) has cleared the Jewel ® Patch Wearable Cardioverter Defibrillator (Patch-WCD) for adult patients aged 18 years and older who are at risk for sudden cardiac ...

Environmental Health Perspectives, a journal funded by the National Institutes of Health (NIH), announced that it would pause new submissions.

Self-paying patients will now be able to access NovoCare Pharmacy directly through the telehealth platform. Novo Nordisk is collaborating with multiple telehealth organizations in an effort to ...

Neoadjuvant PD-1 blockade with dostarlimab enables nonoperative management strategy for large proportion of patients.

The summary below gives an overview of important additions and changes MPR has made to its drug database through the end of April 2025. The chart below provides highlights of key monograph updates ...